MET transcriptional regulator/serine peptidase inhibitor kunitz type 1 panel operating through HGF/c‐MET axis as a prognostic signature in pan‐cancer
Yi Xiang(Nanfang Hospital), Min Shi(Nanfang Hospital), Xingbin Hu(Nanfang Hospital), Qiong Huang(Central South University), Qijing Wu(Nanfang Hospital), Yang Zhao(Peking University), Jiang Yu(Southern Medical University), Yajing Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Shao-wei Li(Wenzhou Medical University), Fei Sun(Nanfang Hospital), Zhiqi Yao(Nanfang Hospital), Bishan Liang(Nanfang Hospital), Wangjun Liao(Sun Yat-sen University)
Cited by 12
Related Papers
Efficacy, Safety, and Correlative Biomarkers of Toripalimab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial (POLARIS-02)
|Journal of Clinical Oncology|2021|350
MSC-regulated lncRNA MACC1-AS1 promotes stemness and chemoresistance through fatty acid oxidation in gastric cancer
|Oncogene|2019|322
Cysteine Dioxygenase 1 Mediates Erastin-Induced Ferroptosis in Human Gastric Cancer Cells
|Neoplasia|2017|308
MoS2-based nanocomposites for cancer diagnosis and therapy
|Bioactive Materials|2021|217